Press Releases

To see only press releases which have been disclosed pursuant to legislation or other regulations, please select “Regulatory releases” below.

Initiator Pharma signs screening agreement with the US National Institute on Drug Abuse to evaluate anti-addictive properties of preclinical assets


September 17, 2021

Initiator Pharma A/S, a clinical-stage Life Science company, today announced that it has signed a screening agreeement with the National Institute on Drug Abuse (NIDA) in the USA in order to investigate the potential benefits of the company’s preclinical assets IPDP2015 and IPNP2015 for improved treatment of addiction.

Initiator Pharma: Financial calendar for 2021


1 February 2021

Initiator Pharma A/S (“Initiator” or the “Company”) announces that the board of directors expects to publish financial reports according to the following schedule: